Single-cell RNA sequencing analysis of human atherosclerotic plaques

Exploratory Score: 0.900 Price: $0.50 Atherosclerosis Human atherosclerotic plaque samples Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting C1Q (C1QA, C1QB, C1QC) in Human atherosclerotic plaque samples. Primary outcome: Identification of cell types and C1Q-related gene expression patterns

Description

Single-cell RNA sequencing analysis was performed on human atherosclerotic plaque (HAP) samples to identify cell types and characterize gene expression patterns. The dataset GSE159677 was analyzed to identify 24 cell clusters and 12 distinct cell types within atherosclerotic plaques. The analysis focused on identifying C1Q-related differentially expressed genes across different cell populations in atherosclerotic tissue. This comprehensive cellular characterization aimed to understand the heterogeneity of cell types present in atherosclerotic plaques and their potential contribution to disease pathogenesis through complement pathway activation.

TARGET GENE
C1Q (C1QA, C1QB, C1QC)
MODEL SYSTEM
Human atherosclerotic plaque samples
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
Complement signaling pathway
SOURCE
extracted_from_pmid_38179058
PRIMARY OUTCOME
Identification of cell types and C1Q-related gene expression patterns

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.900 composite

📖 Wiki Pages

C1QB Protein — Complement Component 1 QproteinC1QB — Complement Component 1Q BetageneRNA Interference (RNAi) Therapies for NeurodegenertherapeuticRNA-Based Therapeutics for Neurodegenerative DiseatherapeuticRNA Targeting Therapy for NeurodegenerationtherapeuticRNA-Targeting Therapies for Neurodegenerative DisetherapeuticRNA-Based Therapeutics for Alzheimer's DiseasetherapeuticRNA Editing TherapeuticstechnologyC1Q Protein (Complement Component 1q)proteinRNA Toxicity PathwaymechanismRNA-Targeted Therapeutics Investment SynthesismechanismRNA-Targeted Therapies in NeurodegenerationmechanismRNA Stability and DecaymechanismRNA Splicing Defects in NeurodegenerationmechanismRNA Splicing Dysregulation in 4R-Tauopathies: A Comechanism

Protocol

Phase 1: Dataset Acquisition and Quality Control — Days 1-3
Download single-cell RNA sequencing dataset GSE159677 from GEO database containing human atherosclerotic plaque samples. Verify data integrity and completeness, ensuring presence of both count matrices and metadata. Load data into R environment using Seurat package (v4.0+). Perform initial quality control filtering: retain cells with 200-6000 detected genes, <20% mitochondrial gene expression, and <10% ribosomal gene expression. Filter genes expressed in at least 10 cells. Calculate quality metrics including number of unique molecular identifiers (UMIs), gene count per cell, and mitochondrial gene percentage. Remove potential doublets using DoubletFinder algorithm with expected doublet rate of 7.5% for 10X Genomics data.

...

Expected Outcomes

  • 1. Primary: Successful identification of 24 distinct cell clusters consolidating into 12 major cell types with >0.7 average silhouette score for cluster quality
  • 2. Cell type diversity: Detection of macrophage subpopulations (40-50% of total cells), endothelial cells (15-20%), smooth muscle cells (10-15%), and lymphocytes (5-10%)
  • 3. C1Q expression patterns: C1QA, C1QB, and C1QC predominantly expressed in macrophage populations (>80% of C1Q+ cells) with distinct subpopulation specificity
  • 4.

...

Success Criteria

  • • Clustering quality: Average silhouette coefficient >0.6 across all clusters and cluster stability >80% in bootstrap resampling
  • • Cell type annotation: >85% of cells assigned to definitive cell types with expression of ≥2 canonical markers per type
  • • C1Q detection sensitivity: C1Q genes detected in ≥5% of total cells with clear cell-type specificity patterns
  • • Statistical robustness: ≥100 significantly differentially expressed genes per major cell type comparison (FDR < 0.05)
  • • Data completeness: <10% missing data after quality control, successful processing of >90% of original cells

...

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.